Are The Pharma Job Cuts Over At Last?
Source Over the past several years, tens of thousands of jobs have been eliminated by the pharmaceutical industry. The reasons are not new: expiring patents on big sellers, shifting priorities on research projects and an ongoing need to convince Wall Street that numbers can be managed no matter what is taking place in the labs. […]
Read More »Category : News
Pharma Exec Charged With Insider Trading
Source A Bristol-Myers Squibb executive was charged with insider trading for buying stock options in three drugmakers that were targeted for acquisition, according to a Federal Bureau of Investigation arrest complaint filed in federal court. Robert Ramnarine, 45, an executive director of pension and savings who lives in East Brunswick, was arrested this morning by […]
Read More »Category : News
FDA Warns Sanofi Vaccine Unit on Manufacturing Violations at Two Facilities
FDA stated this week that Sanofi SA’s (SNY, SAN.FR) vaccine unit violated agency manufacturing rules at two company facilities, and the company has temporarily stopped making a product used to treat bladder cancer to renovate one of the plants. The FDA posted a July 12 warning letter to its website Tuesday involving two Sanofi Pasteur […]
Read More »Category : News
FDA and Contractor Fight Over Web Posting of Scientists’ Emails
FDA’s parent agency told a government contractor that 80,000 pages of confidential employee communications that the company posted on the Internet contained no sensitive or personally identifiable information, documents show. The communications are at the center of a controversial surveillance-gathering operation that monitored a group of whistleblowing scientists critical of the FDA’s process of reviewing […]
Read More »Category : News
Venture Capital Dollars Disappearing in Life Sciences
source File this under ‘some things never change.’ Venture capital investments may be increasing in many sectors, but not in life sciences. Defined as biotechs and medical devices, venture investing fell 9 percent in dollars and 6 percent in the number of deals in the second quarter of the year with $1.4 billion funneled into […]
Read More »Category : News
Clinical Deaths Have Dropped in India. However….
source The number of deaths attributed to clinical trials in India numbered 438 last year, a steep drop from 668 deaths that were recording during the previous year. But the decline was largely attributed to flat growth in clinical trial work in the country and critics continue to maintain that regulations are insufficient to prevent […]
Read More »Category : News
Stada’s Hemofarm Says Drug Safety Restored After FDA Warning
Hemofarm AD, a Serbian drugmaker owned by Stada Arzneimittel AG (SAZ), said it fixed contamination threats in its aseptic production line found by the U.S. Food and Drug Administration, which halted its exports to the U.S. The Vrsac, Serbia-based drugmaker has suspended production for the U.S. market for “commercial reasons†while it continues to “take […]
Read More »Category : News
New Alzheimer Drugs Fail Trial
source The first of several widely anticipated trial results for Alzheimer’s medications this year has just been released and the findings are disappointing. Bapineuzumab, otherwise known as bapi, failed to meet two primary endpoints – change in cognitive and functional performance compared to placebo in Phase III trial in patients with mild-to-moderate Alzheimer’s disease who […]
Read More »Category : News
Italy May Lose Thousands of Drug-Firm Jobs, Industry Lobby Says
Italy May Lose Thousands of Drug-Firm Jobs, Industry Lobby Says Drug companies in Italy may eliminate thousands of jobs due to government spending cuts, including those introduced this month by Prime Minister Mario Monti, according to a trade group and labor unions. “The consequences for companies are clear: disinvestment, delocalization and a worsening of crises […]
Read More »Category : News
Problems With Emerging Markets Trial Data
source The ongoing debate over the growing use of clinical trials in so-called emerging markets has been the proverbial thorn in the side of clinical research organizations. The cost of running these trials in such countries can cost less than in the US, for instance, which appeals to drugmakers. But on-the-ground conditions vary from country […]
Read More »Category : News
